Deborah Turner Kochevar is Director of CHARLES RIVER LABORATORIES INTERNATIONAL, INC.. Currently has a direct ownership of 7,894 shares of CRL, which is worth approximately $1.65 Million. The most recent transaction as insider was on May 13, 2024, when has been sold 559 shares (Common Stock) at a price of $228.41 per share, resulting in proceeds of $127,681. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 7.89K
7.62% 3M change
7.62% 12M change
Total Value Held $1.65 Million

Deborah Turner Kochevar Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 13 2024
BUY
Grant, award, or other acquisition
$127,681 $228.41 p/Share
559 Added 6.61%
7,894 Common Stock
May 15 2023
BUY
Grant, award, or other acquisition
-
664 Added 8.3%
7,335 Common Stock
May 11 2022
BUY
Grant, award, or other acquisition
-
575 Added 7.94%
6,671 Common Stock
Aug 06 2021
SELL
Open market or private sale
$1,433,531 $406.56 p/Share
3,526 Reduced 36.65%
6,096 Common Stock
Aug 06 2021
BUY
Exercise of conversion of derivative security
$417,005 $164.24 p/Share
2,539 Added 20.88%
9,622 Common Stock
May 07 2021
BUY
Grant, award, or other acquisition
-
355 Added 4.77%
7,083 Common Stock

Also insider at

ELAN
Elanco Animal Health Inc Healthcare
DTK

Deborah Turner Kochevar

Director
Wilmington, MA

Track Institutional and Insider Activities on CRL

Follow CHARLES RIVER LABORATORIES INTERNATIONAL, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CRL shares.

Notify only if

Insider Trading

Get notified when an Charles River Laboratories International, Inc. insider buys or sells CRL shares.

Notify only if

News

Receive news related to CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Track Activities on CRL